Lv5
890 积分 2023-11-08 加入
ACG Clinical Guideline: Treatment of Helicobacter pylori Infection
7个月前
已关闭
Intestinal barrier biomarkers in clinical evaluation of patients with inflammatory bowel disease
11个月前
已完结
Biologic therapy for inflammatory bowel disease: Real-world comparative effectiveness and impact of drug sequencing in 13,222 patients within the UK IBD BioResource
1年前
已完结
P084 DEEP REMISSION WITH DOUBLE BIOLOGIC THERAPY: A SUCCESSFUL CASE OF COMBINATION USTEKINUMAB AND VEDOLIZUMAB FOR SEVERE REFRACTORY CROHN'S DISEASE
1年前
已完结
279 COMBINATION THERAPY DOES NOT IMPROVE CLINICAL AND ENDOSCOPIC REMISSION RATES WITH VEDOLIZUMAB OR USTEKINUMAB IN CROHN'S DISEASE AND ULCERATIVE COLITIS
1年前
已完结
Multiple Hepatic Masses in a Patient with Crohn’s disease
1年前
已完结
皖公网安备34019202002308
